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ABSTRACT
Objectives To evaluate missed opportunities and delays
in the diagnosis of HIV in a low prevalence setting over
a 24 year period.
Methods Patients with acute presentations of HIV were
included in a retrospective note based review. Data were
compared from acute presentations in 1985e2001 (88/
241 new patients) with 2005e2007 (99/136 new
patients). The number of recorded clinical and laboratory
clues to infection and subsequent time delays to
diagnosis of HIV were evaluated.
Results The findings reflect the shifting demographics of
HIV in the UK over the past two decades, exemplified by
an eightfold increase in tuberculosis at presentation.
Despite recording clinical stigmata of HIV (clues) in the
notes, the number of missed clues increased, and
many clinicians failed to request HIV testing. The median
delay between presentation and diagnosis reduced
from 5 to 1 day (p<0.001), and mortality dropped from
14% to 4% among patients presenting with acute
symptoms. However, there was still a delay of more
than 30 days before diagnosis for almost one in five
patients.
Conclusions Despite some improvement and better
awareness, there are still significant delays before
hospital doctors consider the diagnosis of HIV for
patients in low prevalence areas, even among some
patient groups with high risk. Hospitals should consider
moving to opt-out routine HIV testing of all medical
admissions.
INTRODUCTION
An estimated 83 000 people infected with HIV were
reported in the UK in 2008, of whom the highest
proportion live in London. HIV prevalence in North
West England is low, with an average of 0.79 per
1000 persons reported infected.1 Among adults aged
over 15 years who had a new diagnosis of HIV
made in 2008, 32% had a CD4 cell count
<2003106/l within 3 months of diagnosis.1
Patients who present late in the course of HIV
disease and with low CD4 cell counts (usually
<2003106/l) have higher mortality,2e4 prolonged
hospital stays, and increased hospital related costs.5
These acute presentations to healthcare profes-
sionals may not be recognised by the non-specialist,
prompting the Department of Health in the UK to
encourage HIV testing in all settings,6 supported by
new guidance on HIV testing issued by national
specialist societies and patient groups in 2008.7
Current guidance recommends that HIV tests be
offered to all persons living in areas of the UKwhere
prevalence exceeds 2 per 1000 and that targeted
testing, based on symptoms, should be conducted
elsewhere.6 General physicians may be confronted
with patients who present with acute disease either
from seroconversion illnesses or from advanced HIV
disease. While seroconversion illnesses may be
diagnostically challenging, advanced HIV generally
results in a number of obvious clues or ‘stigmata’
of immunosuppression and tables of suggestive
conditions are available in HIV guidance for
non-specialists.8
Missed opportunities for the diagnosis of HIV
have been described elsewhere, particularly in low
prevalence areas9 and when patients present with
HIV seroconversion illnesses.10 11 In this paper we
report on a study conducted in the Liverpool
Tropical and Infectious Disease Unit (TIDU)
(box 1), a tertiary referral unit in North West
England, to identify the impact of enhanced
training on the timely diagnosis of HIVamong non-
specialist, general medical healthcare professionals.
Using patient data from a 24 year period, we set
out to assess the number of diagnostic clues that
were recorded and missed at the ﬁrst HIV related
illness presentation to general physicians, to docu-
ment delays to diagnosis of HIV and to identify
factors associated with delay. We compared two
time periods to see if the number of missed clues




A retrospective case notes based review was
performed of all HIV related presentations in
Merseyside that were referred to the TIDU in
Liverpool. Two cohorts of patients were evaluated
and the results from the cohorts were compared.
Period 1 included patients found to be HIV positive
and who were referred to the TIDU, as an inpatient
or outpatient, between 1 January 1983 and 31
December 2001 (ﬁgure 1). The data for this period
were collected in 2002. In period 2 we reviewed case
notes from a similar sized cohort of HIV patients
presenting to the TIDU between January 2005 and
December 2007. The cohort again consisted of
newly diagnosed HIV patients and the data for this
group were collected retrospectively in 2009.
Patients referred solely to the clinics of the Liver-
pool Sexual Health Centre were excluded from
either cohort. A pretested proforma was used to
gather baseline data about patients on their sex,
sexuality, age at HIV diagnosis, country of origin,
previous HIV testing, experience of foreign travel,
and intravenous drug use, together with clinical
and laboratory features of infection and details
of the time between presentation and diagnosis
of HIV. The same proforma was used for both
cohorts.
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Initial training
The initial ﬁndings from the cohort of patients in period 1, related
to delays in diagnosis, were used to train medical students,
accident and emergency (A&E) trainees, general practitioners,
and hospital staff from 2001 to 2006. This was done through
organised teaching sessions with these groups of healthcare
professionals, as it was felt that they were the people most likely
to see these patients initially: educating themwith regard to HIV
testing may have allowed the diagnosis to be made earlier and
thereby reduce the morbidity and mortality associated with
delayed diagnosis. The teachingwas carried out using case studies
of acute presentations of HIV, and a ‘targeted’ approach to testing
was encouraged, based on indicator ﬁndings in the medical
history and examination. Further publicity about the need for
HIV testing was emphasised at other postgraduate events in the
hospitaldfor example, at ‘grand rounds’ and in educational
displays and events for the public and staff on HIV days, etc. The
second cohort was then evaluated and compared to the cohort
from period 1, to assess if continued education among healthcare
workers led to an improvement in the time to diagnosis of HIV,
with reduced delays to testing among these patients.
Definitions used in data collection
We deﬁned acute presentations as being patients with an
unknown HIV status when presenting to hospital with an HIV
related illness that required hospital admission or an urgent
consultant outpatient opinion. A spectrum of HIV related illness
from seroconversion to advanced HIV disease was included.
‘Clues’ to HIV disease were deﬁned as: known epidemiological
and behavioural risk factors, relevant pastmedical history, clinical
stigmata of HIV disease on examination, and baseline investiga-
tion consistent with underlying HIV infection. The number of
clues documented in the initial clerking was recorded (‘recorded
clues’) and compared to those identiﬁed by a specialist during the
same admission, the difference being deﬁned as ‘missed clues’.
Data analysis
The study was registered with the hospital clinical information
audit committee and all personal data were stored and analysed
in accordance with national guidelines.12 Epi info 2000 version
3.5.1 was used to perform statistical analysis using the
ManneWhitney U test and Fisher ’s exact test. These were used
to calculate and compare delays to diagnosis of HIV, frequency
of risk factors, mean number of clues and missed clues, and
median delays to diagnosis within the two cohorts. Interquartile
ranges are given to illustrate the range in diagnostic delays.
RESULTS
Demographics
During period 1, out of a possible 245 patient case notes, 241
(98.4%) were retrieved. Of these, 209 (87%) were male and 207
(86%) were from the UK. In the second period, 136/146 (93.2%)
case notes of patientswere retrieved, 82 (60%) ofwhomweremale
and 59 (43%) were from sub-Saharan Africa. There was, in
tandem, a signiﬁcant (p<0.001) reduction in cases in men who
have sex with men. Using the previous deﬁnitions, we identiﬁed
80/241 (33.2%) presentations as acute in period 1 and 99/136
(72.8%) in period 2 (ﬁgure 1). Baseline demographics are
summarised in table 1. Immediate hospital mortality was 11/80
(14%) admissions in the ﬁrst period and 4/99 (4%) in the second
period (p¼0.04).
Box 1 Details of Tropical and Infectious Disease Unit,
Liverpool
The Tropical and Infectious Disease Unit (TIDU) in Liverpool
provides outpatient and inpatient care for people with HIV, and
was previously located at the University Hospital Aintree, where
same day testing for HIV was available from 1995 onwards. In
December 2001 the TIDU moved to its current site, where
comprehensive HIV services are provided jointly with the Liver-
pool Sexual Health Centre (Department of Genitourinary Medi-
cine), which sees the majority of people with asymptomatic new
presentations of HIV in the Mersey region.
HIV patients added to 
existing database in 
Period 1, 1st Jan 1983 to 
31st Dec 2001 identified
HIV patients added to 
existing database in 
Period 2, 1st Jan 2005 to 
31st Dec 2007 identified
245 case notes identified 
for newly diagnosed HIV 
patients
241 case notes retrieved
4 case notes missing
80 patients identified as 
acute admission
146 case notes identified 
for newly diagnosed HIV 
patients
99 patients identified as 
acute admission
99 patients identified as 
acute admission
Figure 1 Patient identification in the two cohorts.
Table 1 Demographic features of two cohorts of patients presenting




n[99 (%) p Value*
Characteristics
Female 10 12.5 38 38.4 <0.001
Age >40 23 28.8 32 32.3 0.629
Origin
UK 65 81.2 47 47.5 <0.001
SSA 11 13.8 43 43.4 <0.001
Other 4 5.0 9 9.1 0.39
Risks
MSM 42 52.5 18 18.2 <0.001
IVDU 7 8.8 5 5.1 0.377
Travel 26 32.5 56 56.6 0.0015
Expatriate 14 17.5 0 0 <0.001
CSW 2 2.5 0 0 0.198
Where acquired
UK 45 56.3 43 43.4 0.0995
SSA 20 25.0 46 46.5 0.003
N America 9 11.2 2 2.0 0.013
Elsewhere 6 7.5 8 8.1 1
Presentation stage
CD4 <200 50 62.5 67 67.7 0.528
CD4 >200 27 33.8 29 29.3 0.627
CD4 not known 3 3.7 3 3.0 1
*Fisher’s exact test.
CSW, commercial sex worker; IVDU, intravenous drug user; MSM, men who have sex with
men; SSA, sub-Saharan Africa.
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Clinical findings
The clinical stigmata of HIV disease at the time of acute
presentation revealed the importance of a history of previous
sexually transmitted infection (STI), dry skin, pneumonia, and
chronic diarrhoea as well as the social and travel history (table 2).
Lymphadenopathy, respiratory distress, oral candidiasis, and
dermatitis were the most common clinical signs in both periods.
The most often recorded haematological abnormalities were
anaemia and lymphopenia, together with thrombocytopenia and
hyperglobulinaemia. The mean (SD) recorded clinical clues were
5.8 (2.54) and 4.5 (2.16) in periods 1 and 2, respectively (p<0.01);
the mean number of missed clues increased signiﬁcantly between
the two cohorts, rising from 1.8 (2.01) to 4.0 (2.51) (p<0.01).
Diagnosis of HIV associated diseases and opportunistic
infections
In both periods, approximately 60% of people who presented
acutely had opportunistic infections (OI), indicating advanced
HIV disease, and had CD4 white cell counts <200 106/l (data
not shown). The most common AIDS deﬁning diagnoses were
Pneumocystis jirovecii pneumonia (PCP) in 21 (28.8%) and AIDS
related malignancies in 5 (6.8%) in period 1, and PCP in 22
(23.2%) and tuberculosis (TB) in 24 (23.2%) in period 2. The
proportion of cases co-infected with TB rose eightfold from 2.7%
to 23.2% between the two cohorts. A further 30% presented
with HIV related conditions such as herpes zoster, pneumo-
coccal pneumonia, and oral candidiasis, and 16.4% and 8.1% of
the cohorts, respectively, presented with acute HIV seroconver-
sion illnesses.
Delays to diagnosis
The median delays to diagnosis of HIV (table 3) were 5 and
1 days, respectively, between the two cohorts (p<0.001), but
with a skewed pattern of distribution, with the greatest reduc-
tion seen in patients presenting with OI/AIDS (6 to 1 day;
p<0.001). There was a delay of more than 30 days between
presentation and diagnosis in 31/171 (18.1%) patients, with
a non-signiﬁcant trend for this to be more common for women
(12/47; 25.6%) than for men (19/124; 15.3%) (p¼0.19). Similar
non-signiﬁcant trends were seen in patients with seroconversion
illness (5/20; 25%) compared to those presenting with obvious
late stage disease (14/100; 14%).
DISCUSSION
In these cohorts of people presenting with HIV over more than
two decades, there has been no decrease in the number or
proportion of people presenting acutely. We documented
a reduction in the average time taken to diagnose HIV in these
groups as junior doctors and generalists increased their aware-
ness through organised educational sessions, as well as national
awareness programmes. However, despite overall improvement
in the recognition of HIV, some long delays remained. These
may have been exacerbated by a paucity of clinical documen-
tation in the second period, as reﬂected in the increasing
proportion of ‘missed’ as opposed to ‘recorded’ clues in the case
notes (table 2). There was no signiﬁcant improvement in the
time delay to diagnosis in women, in those aged over 40, in
those from sub-Saharan Africa,5 and those with a seroconversion
illness. The latter requires a high index of suspicion and suggests
further need for improvement in clinical education and training
for non-specialists to recognise presentations.8 10
Table 2 Recorded clues (medical history, clinical examination and




N[99 % p Value*
Past medical history
Travel history 32 41.6 40 40.4 0.879
MSM 28 36.4 12 12.1 <0.001
STI 9 11.7 7 7.1 0.305
Dry skin 8 10.4 23 23.2 0.03
IVDU 7 9.1 5 5.1 0.37
HBV infection 6 7.8 0 0 0.006
Pneumococcal pneumonia 5 6.5 18 18.2 0.025
Oral candidiasis 5 6.5 16 16.2 0.06
Chronic diarrhoea 7 9.1 3 3.0 0.107
Shingles 3 3.9 4 4.0 1
TB infection 2 2.6 3 3.0 1
Blood transfusion 2 2.6 3 3.0 1
Refugee 1 1.3 5 5.1 0.23
Clinical examination
Lymphadenopathy 19 24.7 35 35.4 0.141
Unexplained hypoxia 19 24.7 37 37.4 0.08
Oral candidiasis 17 22.1 22 22.2 1
Other (cachexia, etc) 16 20.8 0 0 <0.001
Neurological deficit 14 18.2 15 15.1 0.683
Dermatitis 9 11.7 29 29.3 0.005
Maculopapular rash 7 9.1 10 10.1 1
Shingles scar 2 2.6 8 8.1 0.108
KS lesion 2 2.6 7 7.1 0.302
Blood results
Anaemia 38 49.3 60 60.6 0.168
Lymphopenia 28 36.4 30 30.3 0.422
Increased globulins 28 36.4 57 57.6 0.006
Thrombocytopenia 16 20.8 10 10.1 0.06
*Fisher’s exact test.
HBV, hepatitis B virus; IVDU, intravenous drug user; KS, Kaposi’s sarcoma; MSM, men who
have sex with men; STI sexually transmitted infection; TB, tuberculosis.
Table 3 Median delay in days and interquartile range (IQR) from




N[99 IQR p Value*
Total 5 2e27.5 1 0e9 <0.001
Characteristics
Female 7 4e174 2.5 0e15 0.05
Male 5 2e18 1 0e7 <0.001
Age >40 years 5 1e15.5 2.5 0e9 0.08
Age #40 years 5.5 2.5e33.5 1 0e7 <0.001
Origin
UK 5.0 2e34 0 0e9 <0.001
SSA 6.5 1e9 2 0e9 0.29
Other 5.5 3.5e41.5 1 0e5 0.12
Risks
MSM 6.0 1.5e29.5 0 0e11 0.005
IVDU 4.0 3e5 6 5e31 0.16
Travel 5.0 1e77 1.5 0e7 0.04
CD4
CD4 <200 5 N¼46 2e13 2 N¼67 0e9 0.004
CD4 >200 5 N¼25 1e34 0 N¼29 0e12 0.02
Presenting illness
OI/AIDS 6 2e13 1 0e7 <0.001
Non AIDS HIV related 5 4e37 2 0e13 0.21
HIV seroconversion 4.5 0.5e144.5 0 0e6 0.06
*ManneWhitney U test.
IVDU, intravenous drug user; MSM, men who have sex with men; OI, opportunistic
infection; SSA, sub-Saharan Africa.
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The Merseyside cohorts illustrate the nationwide shift in
demographics of HIV infection,13 and the corresponding change
in patterns of presentation, with more HIV related reactivation
of TB in the later time period.5 14 Our study did not take into
account the contribution of patients with poor English skills,
reported to be a contributory factor in delayed HIV diagnosis in
TB patients.15 While the differences seen in social, travel, and
medical history reﬂect these shifting demographics, the clinical
signs were similar in both time periods (table 2) and provide
a useful checklist for the non-specialist.
Previous studies on missed opportunities for timely and
accurate diagnoses of HIV infections have shown that delays to
diagnosis are common, even in late presentations, especially for
heterosexual and older people who do not ﬁt the HIV risk proﬁle
‘stereotype’.16 Some delays are patient related, and patients who
do not perceive themselves to be at risk of HIV are less likely to
access healthcare and are more likely to present with late stage
infections.5 More complex factors lead to reluctance of some
high risk groups of migrants from seeking diagnostic testing.17 18
Delays occur regardless of specialty19 and, while some
patients present themselves late in the course of HIV infection,
the majority have contact with medical professionals during
earlier stages of the disease and, as we found, many have obvious
stigmata of HIV. Similar failures to consider obvious stigmata
have been reported in various clinic settings in Boston, USA,
where patients made a median of ﬁve visits to outpatient and
emergency room clinics and HIV was only considered in 27% of
visits in which clues were identiﬁed.20 Almost one in ﬁve of our
patients had symptoms for more than 30 days before diagnosis,
although the median delay to diagnosis after presentation was
only a few days, similar to previous US21 and UK reports.5 The
non-signiﬁcant but increased delay in diagnosing intravenous
drug users may require further exploration.
Clinical triggers that are repeatedly missed by clinicians are
lymphadenopathy,22 oral candidiasis, herpes and other oral
lesions,23 and herpes zoster.24 Clues in the routine biochemical
screen and blood count are commonly missed including hyper-
globulinaemia, anaemia, neutropenia, lymphopenia, and
thrombocytopenia.25 Acute seroconversion illness is under-
diagnosed10 and may present with a variety of syndromes
including meningoencephalitis.26 The need to consider HIV in all
patients with a lymphoma has been re-emphasised recently,27 28
as has the need for expanded testing in intensive care units.29
Our ﬁndings indicate an improvement in diagnostic delays in
hospital inpatients in known risk groups, although there is no
deﬁnite link between our attempts to provide refresher courses
for generalists and the improved early detection of HIV.
Furthermore, the increased national awareness raising among
some high risk groups does not appear to have had an effect on
the rates of acute presentations over time, in part because of the
shift in the epidemiology of HIV in recent years. Our hospital
has seen some improvement in the diagnosis of HIV, but there is
no room for complacency. A shift to routine opt-out testing at
times of contact with medical professionals30 31 would overcome
the concerns of generalists about when to offer HIV testing, and
to whom, and would improve the timely diagnosis of asymp-
tomatic and early HIV infection. However, logistic and ethical
issues continue to hinder the introduction of routine testing in
some emergency rooms,32 33 and the most cost effective and
non-intrusive way to overcome such obstacles needs further
evaluation in low prevalence settings in the UK. This is
even more pertinent in light of the recent evidence that early
initiation of antiretroviral therapy is associated with better
outcomes.34 35
Findings from this study were limited by the method and type
of case reporting, but this remained relatively standard between
the two cohorts examined. While the two cohorts were of
similar sizes, the second accumulated over a shorter time span
reﬂecting higher incidence, which may have had an impact on
(enhanced) recognition of signs. The reliance on routine docu-
mentation within medical records was a limitation, and missing
data may have compromised full evaluation. Furthermore, we do
not have data on previous contacts with primary care. The
relative clinical signiﬁcance of missed clues is not accounted for,
with all being given the same weighting, when in reality some
are stronger indicators of underlying HIV than others. However,
there is little evidence to suggest this resulted in any systematic
error favouring a particular subgroup or time period. Further-
more, contemporaneous reporting to the North West Moni-
toring System suggests our ﬁndings are in keeping with regional
shifts in patient characteristics.13
CONCLUSION
As elsewhere in the UK, there has been a major demographic
shift in HIV presentations, which in turn has had an impact on
HIV diagnosis. We showed a reduction in the median delay to
diagnosis, but opportunities for testing are still being missed,
particularly in women, older people, and those with serocon-
version illnesses. Our data suggest that a change from targeted
to routine ‘opt-out’ testing in acute medical admissions in the
UK may be appropriate in order to reduce these delays to making
a diagnosis of HIV and related illnesses. This would, in turn,
improve the prognosis for those diagnosed early and reduce
hospital stays.
Main messages
< There has been a major demographic shift in the UK, which
has had an impact on HIV presentations to primary and
secondary care.
< When patients with underlying HIV infection present to
healthcare providers, there are often several clues related to
the underlying infection.
< Opportunities to make the diagnosis of HIV early in the
disease process are being missed, potentially leading to
increased morbidity and mortality.
< Continued education among generalists may improve rates of
HIV diagnosis.
< ‘Opt-out’ testing may be an appropriate approach to testing
patients in order to reduce the delays in diagnosis.
Current research questions
< How can the recognition of clues to the diagnosis of HIV be
improved in primary care?
< How can the recognition of clues to the diagnosis of HIV be
improved in secondary care?
< What is the best educational programme to maintain
diagnostic acumen in a setting with low prevalence of HIV?
< Is the introduction of an ‘opt-out’ testing approach for HIV
feasible and cost effective in acute medical admission units,
especially in low prevalence settings?
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